| 摘要 |
The present invention provides a pharmaceutical composition for the treatment of ocular hypertension which comprises an oculo-hypotensively synergistic combination of (a) a 13,14-dihydro-15-ketoprostaglandin compound, and (b) a .beta.-adrenergic blocker, in association with a pharmaceutically acceptable carrier, diluent or excipient.
|
